Literature DB >> 22031247

Obstetric and neonatal outcomes of cancer treated during pregnancy.

Janelle R Walton1, Mona R Prasad.   

Abstract

Cancer diagnosed during pregnancy is a rare occurrence with an incidence of 0.1% of all pregnancies. However, its management can be challenging at times as one balances maternal benefit to fetal risk. Various treatment modalities are used in this context including surgical intervention, chemotherapy, and radiologic therapy. This review seeks to address the impact of pregnancy on disease as well as the effect of malignancy and its treatment on both mother and fetus. Attention is focused on the more common malignancies associated with pregnancy: cervix, breast, melanoma, and hematologic malignancies. In addition, special emphasis is placed on timing of delivery and how that affects neonatal outcomes.

Entities:  

Mesh:

Year:  2011        PMID: 22031247     DOI: 10.1097/GRF.0b013e318236e781

Source DB:  PubMed          Journal:  Clin Obstet Gynecol        ISSN: 0009-9201            Impact factor:   2.190


  3 in total

Review 1.  Effects of fetal exposure to maternal chemotherapy.

Authors:  Jana Dekrem; Kristel Van Calsteren; Frédéric Amant
Journal:  Paediatr Drugs       Date:  2013-10       Impact factor: 3.022

2.  Malignancies associated with pregnancy: an analysis of 21 clinical cases.

Authors:  Y Liu; Y Liu; Y Wang; X Chen; H Chen; J Zhang
Journal:  Ir J Med Sci       Date:  2014-02-23       Impact factor: 1.568

Review 3.  Chemotherapy against cancer during pregnancy: A systematic review on neonatal outcomes.

Authors:  Susanna Esposito; Rossana Tenconi; Valentina Preti; Elena Groppali; Nicola Principi
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.